Uncategorized Our portfolio company Artiria Medical secured a CHF 2.7M grant from one of the most competitive programs in Europe
Uncategorized Venture Capital Funding in Switzerland has experienced a tremendous growth over the past 10 years and is expected to keep booming
Uncategorized Our portfolio company Kairos Fire joined force with TF1 PUB to measure the impact of TV campaigns
Uncategorized Our portfolio company, Aspivix, achieved a new great milestone through the completion of the comparative clinical trial phase contributing
Uncategorized Our portfolio company, Neo Medical, closes Swisscom Ventures-lead USD 20.6M financing round
Uncategorized Go and read the latest interview of Vincent Lefauconnier, CEO of our portfolio company Neomedical
Uncategorized Our portfolio company Scailyte successfully closed its Serie A financing round, welcoming two additional new investors.
